Enrofloxacin

Enrofloxacin is a fluoroquinolone antibiotic used in veterinary medicine to treat bacterial infections in animals. Enrofloxacin is a quinolinemonocarboxylic acid that is 1,4-dihydroquinoline-3-carboxylic acid substituted by an oxo group at position 4, a fluoro group at position 6, a cyclopropyl group at position 1 and a 4-ethylpiperazin-1-yl group at position 7. It is a veterinary antibacterial agent used for the treatment of pets. Among its listed roles, it functions as a antibacterial agent, an antineoplastic agent and an antimicrobial agent. It is a quinolinemonocarboxylic acid, a quinolone, an organofluorine compound, a N-alkylpiperazine, a N-arylpiperazine and a member of cyclopropanes. It is grouped under the following drug class(es): Fluoroquinolones, Quinolones and Topoisomerase inhibitors. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Baytril and endrofloxicin. Its PubChem CID is 71188.